Effects of growth hormone overexpression and growth hormone resistance on neuroendocrine and reproductive functions in transgenic and knock-out mice

Proceedings of the Society for Experimental Biology and Medicine

Volumn 222, Issue 2, 1999, Pages 113-123

  Bartke, Andrzej ^a   Chandrashekar, Varadaraj ^a   Turyn, Daniel ^b   Steger, Richard W ^a   Debeljuk, Luciano ^a   Winters, Todd A ^c   Mattison, Julie A ^a   Danilovich, Natalia A ^a   Croson, William ^a   Wernsing, Danyel R ^a   Kopchick, John J ^d  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Instituto de Quimica y Fisicoquimica Biologicas Buenos Aires   (Argentina)

^c SOUTHERN ILLINOIS UNIVERSITY   (United States)

^d OHIO UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GONADORELIN; GROWTH HORMONE; GROWTH HORMONE RECEPTOR; SOMATOMEDIN C;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; CONTROLLED STUDY; DWARFISM; FEMALE; FETUS WEIGHT; GENE OVEREXPRESSION; HORMONAL REGULATION; HORMONE PROTEIN COMPLEX; HORMONE RELEASE; HORMONE RESISTANCE; KNOCKOUT MOUSE; MALE; MOUSE; NEUROENDOCRINE DISEASE; NEWBORN; NONHUMAN; OBESITY; PHENOTYPE; REPRODUCTION; SHORT SURVEY; TRANSGENIC MOUSE;

ANIMALIA; MUS MUSCULUS;

EID: 0032717947     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1373.1999.d01-121.x     Document Type: Short Survey

References (92)

1. Bartke A, Cecim M, Tang K, Steger RW, Chandrashekar V, Turyn D. Neuroendocrine and reproductive consequences of overexpression of growth hormone in transgenic mice. Proc Soc Exp Biol Med 206:345-359, 1994.
2. Hurley DL, Bartke A, Wagner TE, Wee BE, Phelps CJ. Increased hypothalamic somatostatin expression in mice transgenic for bovine or human GH. J Neuroendocrinol 6:539-548, 1994.
3. Hurley DL, Phelps CJ. Altered growth hormone releasing hormone (GHRH) mRNA expression in transgenic mice with excess or deficient endogenous GH. Mol Cell Neurosci 4:237-244, 1993.
4. Sotelo AI, Bartke A, Turyn D. Effects of bovine growth hormone (GH) expression in transgenic mice on serum and pituitary immunoreactive mouse GH levels and pituitary GH-releasing factor binding sites. Acta Endocrinol 129:446-452, 1993.
5. Balbis A, Bartke A, Turyn D. Overexpression of bovine growth hormone in transgenic mice is associated with changes in hepatic insulin receptors and in their kinase activity. Life Sci 59:1363-1371, 1996.
6. Dominici FP, Balbis A, Bartke A, Turyn D. Role of hyperinsulinemia on hepatic insulin binding and insulin receptor autophosphorylation in the presence of high growth hormone (GH) levels in transgenic mice expressing GH gene. J Endocrinol 159:15-25, 1998.
7. Cecim M, Ghosh PK, Esquifino AI, Began T, Wagner TE, Yun JS, Bartke A. Elevated corticosterone levels in transgenic mice expressing human or bovine growth hormone genes. Neuroendocrinology 53:313-316, 1991.
8. Cecim M, Alvarez-Sanz M, Van de Kar L, Milton S, Bartke A. Increased plasma corticosterone levels in bovine growth hormone (bGH) transgenic mice: Effects of ACTH, GH, and IGF-1 on in vitro adrenal corticosterone production. Transgenic Res 5:187-192, 1996.
9. Tang K, Bartke A, Gardiner CS, Wagner TE, Yun JS. Gonadotropin secretion, synthesis, and gene expression in two types of bovine growth hormone transgenic mice. Biol Reprod 49:346-353, 1993.
10. Steger RW, Bartke A, Parkening TA, Collins T, Cerven R, Yun JS, Wagner TE. Effects of chronic exposure to bovine growth hormone (bGH) on the hypothalamic-pituitary axis in transgenic mice: Relationship to the degree of expression of the PEPCK-bGH hybrid gene. Transgenics 1:245-253, 1994.
11. Cecim M, Kerrr J, Bartke A. Effects of bovine growth hormone (bGH) transgene expression or bGH treatment on reproductive functions in female mice. Biol Reprod 52:1144-1148, 1995.
12. Cecim MC, Kerr J, Bartke A. Infertility in transgenic mice overexpressing the bovine growth hormone gene: Luteal failure secondary to prolactin deficiency. Biol Reprod 52:1162-1166, 1995.
13. Cecim M, Fadden C, Kerr J, Steger R, Bartke A. Infertility in transgenic mice overexpressing the bovine growth hormone gene: Disruption of the neuroendocrine control of prolactin secretion during pregnancy. Biol Reprod 52:1187-1192, 1995.
14. Lobie PE, Garcia-Aragon J, Lincoln DT, Barnard R, Wilcox JN, Waters MJ. Localization and ontogeny of growth hormone receptor gene expression in the central nervous system. Dev Brain Res 74:225-233, 1993.
15. Nyberg F, Burman P. Growth hormone and its receptors in the central nervous system: Location and functional significance. Horm Res 45:18-22, 1996.
16. Marks JL, Porte D Jr., Baskin DG. Localization of type I insulin-like growth factor receptor messenger RNA in the adult rat brain by in situ hybridization. Mol Endocrinol 5:1158-1168, 1991.
17. Mattison J, Bartke A, Steger RW. Decreased gonadotropin-releasing hormone secretory response to N-methyl-D L-aspartic acid stimulation in growth hormone (GH) transgenic male mice. Society for Neuroscience, Abstract No. 244.13, Vol 24, 1998.
18. Bourguignon J-P, Gérard A, Franchimont P. Direct activation of gonadotropin-rerleasing hormone secretion through different receptors to neuroexcitatory amino acids. Neuroendocrinology 49:402-408, 1989.
19. Lopez FJ, Donoso AO, Negro-Vilar A. Endogenous excitatory amino acids and glutamate receptor subtypes involved in the control of hypothalamic luteinizing hormone-releasing hormone secretion. Endocrinology 130:1986-1992, 1992.
20. Choudary JB, Greenwald G. Luteotropic complex of the mouse. Anat Rec 163:373-388, 1969.
21. Barkley MS, Bradford GE, Geschwind II. The pattern of plasma prolactin concentration during the first half of mouse gestation. Biol Reprod 19:291-296, 1978.
22. Kirkwood RN, Thacker PA, Laarveld B. The influence of exogenous growth hormone on ovulation rate in gilts-fed diets with different energy and protein contents. Can J Anim Sci 69:265-268, 1989.
23. Danilovich NA, Cao WG, Bartke A, Winters TA. In situ ovarian follicle apoptosis in bGH-transgenic and nontransgenic mice. [abstract] Proceedings of the 31st Annual Meeting of the Society for the Study of Reproduction, 58:73, 1999.
24. Cao WG, Danilovich NA, Hausler CL, Bartke A, Winters TA. In situ gene expression of ovarian steroidogenic enzymes in bGH-transgenic and nontransgenic mice. [abstract] Proceedings of the 31st Annual Meeting of the Society for the Study of Reproduction, 58:187, 1999.
25. Bartke A, Amador AG, Meliska CJ, Yun JS, Wagner TE. Neuroendocrine function, sexual behavior, and fertility in transgenic mice expressing growth hormone genes. In: Waites GMH, Frick J, Baker G, Eds. Current Advances in Andrology, Salzburg, Proceedings of the VIth International Congress of Andrology. Bologna: Monduzzi Editore, International Proceedings Division, pp295-301, 1997.
26. Cecim M, Bartke A, Yun JS, Wagner TE. Growth allometry of transgenic mice expressing the mouse metallothionein-I/bovine growth hormone gene. Transgene 1:125-132, 1993.
27. Quaife CJ, Mathews LS, Pinkert CA, Hammer RE, Brinster RL, Palmiter RD. Histopathology associated with elevated levels of growth hormone and insulin-luce growth factor I in transgenic mice. Endocrinology 124:40-48, 1989.
28. Naar EM, Bartke A, Majumdar SS, Buonomo FC, Yun JS, Wagner TE. Fertility of transgenic female mice expressing bovine growth hormone or human growth hormone variant genes. Biol Reprod 45:178-187, 1991.
29. Chandrashekar V, Bartke A. Influence of hypothalamus and ovary on pituitary function in transgenic mice expressing the bovine growth hormone gene and in growth hormone-deficient Ames dwarf mice. Biol Reprod 54:1002-1008, 1996.
30. Tang K, Bartke A, Gardiner CS, Wagner TE, Yun JS. Testosterone feedback on gonadotropin secretion and gene expression in transgenic mice expressing human growth hormone gene. J Androl 15:9-14, 1994.
31. Vidal S, Stefaneanu L, Kovacs K, Yamada S, Bartke A. Pituitary estrogen receptor α and dopamine subtype 2 receptor gene expression in transgenic mice with overproduction of heterologous growth hormones. Histochem Cell Biol 111:235-241, 1999.
32. Bartke A, Steger RW, Hodges SL, Parkening TA, Collins TJ, Yun JS, Wagner TE. Infertility in transgenic female mice with human growth hormone expression: Evidence for luteal failure. J Exp Zool 248:121-124, 1988.
33. Stefaneanu L, Kovacs K, Bartke A, Mayerhofer A, Wagner TE. Pituitary morphology of transgenic mice expressing bovine growth hormone. Lab Invest 68:584-591, 1993.
34. Mayo KE, Hammer RE, Swanson LW, Brinster RL, Rosenfeld MG, Evans RM. Dramatic pituitary hyperplasia in transgenic mice expressing a human growth hormone releasing factor gene. Mol Endocrinol 2:606-612, 1988.
35. Chandrahekar V, Bartke A. Pituitary and testicular function in adult transgenic mice expressing the human growth hormone-releasing hormone gene. Soc Study Reprod Abstract No. 462, p198, 1997.
36. Orian JM, Snibson K, Stevenson JL, Brandon MR, Herington AC. Elevation of growth hormone (GH) and prolactin receptors in transgenic mice expressing ovine GH. Endocrinology 128:1238-1246, 1991.
37. Turyn D, Bartke A. Pharmacokinetics of radioiodinated human and ovine growth hormones in transgenic mice expressing bovine growth hormone. Transgenic Res 2:219-226, 1993.
38. Sotelo AI, Dominici FP, Engbers C, Bartke A, Talamantes F, Turyn D. Growth hormone-binding protein (GHBP) in normal mice and in transgenic mice expressing bovine growth hormone gene. Am J Physiol 268:E745-E751, 1995.
39. Balbis A, Dellacha JM, Calandra RS, Bartke A, Turyn D. Down regulation of masked and unmasked insulin receptors in the liver of transgenic mice expressing bovine growth hormone gene. Life Sci 51:771-778, 1992.
40. Balbis A, Bartke A, Turyn D. Overexpression of bovine growth hormone in transgenic mice is associated with changes in hepatic insulin receptors and in their kinase activity. Life Sci 59:1363-1371, 1996.
41. Dominici FP, Balbis A, Bartke A, Turyn D. Role of hyperinsulinemia on hepatic insulin binding and insulin receptor autophosphorylation in the presence of high growth hormone (GH) levels in transgenic mice expressing GH gene. J Endocrinol 159:15-25, 1998.
42. Kajiura LJ, Rollo CD. A mass budget for transgenic "supermice" engineered with extra rat growth hormone genes: Evidence for energetic limitation. Can J Zool 72:1010-1017, 1994.
43. Kajiura LJ, Rollo CD. The ontogeny of resource allocation in giant transgenic rat growth hormone mice. Can J Zool 74:492-507, 1996.
44. Rollo CD, Carlson J, Sawada M. Accelerated aging of giant transgenic mice is associated with elevated free radical processes. Can J Zool 74:606-620, 1996.
45. Rollo CD, Foss J, Lachmansingh E, Singh R. Behavioural rhythmicity in transgenic growth hormone mice: Trade-offs, energetics, and sleep-wake cycles. Can J Zool 75:1020-1034, 1997.
46. Rollo CD, Rintoul J, Kajiura LJ. Lifetime reproduction or giant transgenic mice: The energetic stress paradigm. Can J Zool 78:1336-1345, 1997.
47. Pendergast WR, Li Y, Jiang D, Wolf NS. Decrease in cellular replicative potential in "giant" mice transfected with the bovine growth hormone gene correlates to shortened life span. J Cell Physiol 156:96-103, 1993.
48. Steger RW, Bartke A, Cecim M. Premature ageing in transgenic mice expressing growth hormone genes. J Reprod Fertil (Suppl) 46:61-75, 1993.
49. Miller DB, Bartke A, O'Callaghan JP. Increased glial fibrillary acidic prolein (GFAP) levels in the brains of transgenic mice expressing the bovine growth hormone (bGH) gene. Exp Gerontol 30:383-400, 1995.
50. Brown-Borg HM, Borg KE, Meliska CJ, Bartke A. Dwarf mice and the ageing process. Nature 384:33, 1996.
51. Bartke A. Growth hormone and aging. Endocrine 8:103-108, 1998.
52. Bartke A, Brown-Borg HM, Bode AM, Carlson J, Hunter WS, Bronson RT. Does growth hormone prevent or accelerate aging? In: Experimental Gerontology (Proc. 3rd Int. Symp on Neurbiol and Neuroendocrinol of Aging), Vol 33:675-687, 1998.
53. Rosenfeld RG, Rosenbloom AL, Guevara-Aguirre J. Growth hormone (GH) insensitivity due to primary GH receptor deficiency. Endocr Rev 15:369-390, 1994.
54. Chen WY, Wight DC, Metha BV, Wagner TE, Kopchick JJ. Glycine 119 of bovine growth hormone is critical for growth-promoting activity. Mol Endocrinol 5:1845-1852, 1991.
55. Chen WY, Chen NY, Yun J, Wagner TE, Kopchick JJ. In vitro and in vivo studies of antagonists: Effects of human growth hormone analogs. J Biol Chem 269:15892-15897, 1994.
56. Sotelo AI, Bartke A, Kopchick JJ, Knapp JR, Turyn D. Growth hormone (GH) receptors, binding proteins and IGF-1 concentrations in the serum of transgenic mice expressing bovine GH agonist or antagonist. J Endocrinol 158:53-59, 1998.
57. Ultsch M, de Vos AM. Crystals of human growth hormone-receptor complexes: Extracellular domains of the growth hormone and prolactin receptors and a hormone mutant designed to prevent dimerization. J Mol Biol 231:1133-1136, 1993.
58. Ruan W, Knapp J, Chen W, Kopchick JJ, Kleinberg DL. Mammary gland development is impaired in transgenic mice overexpressing a bovine growth hormone antagonist. Endocr Soc, Abstract No. P1-121, p165, 1997.
59. Harding PA, Wang X, Okada S, Chen WY, Wan W, Kopchick JJ. Growth hormone (GH) and a GH antagonist promote GH receptor dimerization and internalization. J Biol Chem 271:6708-6712, 1996.
60. Zhou Y, Xu BC, Maheshwari HG, He L, Reed M, Lozykowski M, Okada S, Wagner TE, Cataldo LA, Coschigano K, Baumann G, Kopchick JJ. A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (The Laron mouse). Proc Natl Acad Sci U S A 94:13215-13220, 1997.
61. Chandrashekar V, Bartke A, Coschigano KT, Kopchick JJ. Pituitary and testicular function in growth hormone receptor gene knock-out mice. Endocrinology 140:1082-1088, 1999.
62. Wernsing D, Zaczek D, Kopchick J, Bartke A. Fetal and placental development, length of gestation, and pregnancy outcome in growth hormone receptor deficient mice. 32nd Annual Meeting Soc Study Reprod, Abstract No. 108, p127, 1999.
63. Marsden HM, Bronson FH. Estrous synchrony in mice: Alterations by exposure to male urine. Science 144:1469, 1964.
64. Bartke A, Croson WB, Kopchick JJ. Effects of targeted disruption of the growth hormone receptor gene on male sexual behavior and ability to induce estrus synchrony. 24th Annual Meeting Am Soc Androl, Abstract No. 3, p27, 1999.
65. Danilovich N, Wernsing D, Coschigano KT, Kopchick JJ, Bartke A. Deficits in female reproductive function in GH-R-KO mice: Role of IGF-1. Endocrinology 140:2637-2640, 1999.
66. Copeland KC, Kuehl TJ, Castracane VD. Pubertal endocrinology of the baboon: Elevated somatomedin-C/insulin-like growth factor 1 at puberty. J Clin Endocrinol Metab 55:1198-1201, 1982.
67. Hiney JK, Srivastava V, Nyberg CL, Ojeda SR, Dees WL. Insulin-like growth factor 1 of peripheral origin acts centrally to accelerate the initiation of female puberty. Endocrinology 137:3717-3728, 1996.
68. Adashi EY, Resnick CE, D'Ercole AJ, Svoboda ME, Van Wyk JJ. Insulin-like growth factors as intraovarian regulators of granulosa cell growth and function. Endocr Rev 6:400-418, 1985.
69. Chubb C. Sexual behavior and fertility of little mice. Biol Reprod 37:564-569, 1987.
70. Baker J, Hardy MP, Zhou J, Bondy C, Lupu F, Bellvé AR, Efstratiadis A. Effects of an IGF-1 gene null mutation on mouse reproduction. Mol Endocrinol 10:903-918, 1996.
71. Bartke A. Genetic models in the study of anterior pituitary hormones. In: Shire JGM, Ed. Genetic Variation in Hormone Systems. Boca Raton, FL: CRC Press, pp113-126, 1979.
72. Roux M, Bartke A, Dumont F, Dubois MP. Immunohistological study of the anterior pituitary glandpars distalis and pars intermedian dwarf mice. Cell Tiss Res 223:415-420, 1982.
73. Li S, Crenshaw BE III, Rawson EJ, Simmons DM, Swanson LW, Rosenfield MG. Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1. Nature 347:528-533, 1990.
74. Sornson MW, Wu W, Dasen JS, Flynn SE, Norman DJ, O'Connell SM, Gukovsky I, Carriere C, Ryan AK, Miller AP, Zuo L, Gleiberman AS, Andersen B, Beamer WG, Rosenfeld MG. Pituitary lineage determination by the prophet of pit-1 homeodomain factor defective in Ames dwarfism. Nature 384:327-333, 1996.
75. van Buul-Offers S, Veda I, Van den Brande JL. Biosynthetic somatomedin C (SM-C/IGF-1) increases the length and weight of Snell dwarf mice. Pediatr Res 20:825-827, 1986.
76. Chandrashekar V, Bartke A. Induction of endogenous insulin-like growth factor-1 secretion alters the hypothalamic-pituitary-testicular function in growth hormone-deficient adult dwarf mice. Biol Reprod 48:544-551, 1993.
77. Bartke A, Lloyd CW. Influence of prolactin and pituitary isografts on spermatogenesis in dwarf mice and hypophysectomized rats. J Endocrinol 46:321-329, 1970.
78. Bartke A, Goldman BD, Bex F, Dalterio S. Effects of prolactin (PRL) on pituitary and testicular function in mice with hereditary PRL deficiency. Endocrinology 101:1760-1766, 1977.
79. Borg KE, Brown-Borg HM, Bartke A. Assessment of the primary adrenal cortical and pancreatic hormone basal levels in relation to plasma glucose and age in the unstressed Ames dwarf mouse. Proc Soc Exp Biol Med 210:126-133, 1995.
80. Chubb C. Animal models of physiologic markers of male reproduction: Genetically defined infertile mice. Environ Health Perspect 74:15-29, 1987.
81. Bartke A. Influence of prolactin on male gonadal function. In: Clauser H, Gautray J-P, Eds. Prolactin Neurotransmission et Fertilite. Paris: Masson, pp117-126, 1982.
82. Horseman ND, Zhao W, Montecino-Rodriquez E, Tanaka M, Nakashima K, Engle SJ, Smith F, Markoff E, Dorshkind K. Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of the prolactin gene. EMBO J 16:101-110, 1997.
83. Ormandy CJ, Camus A, Barra J, Damotte D, Lucas B, Buteau H, Edery M, Brousse N, Babinet C, Binait N, Kelly PA. Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse. Genes Dev 11:167-178, 1997.
84. Romero MI, Phelps CJ. Prolactin replacement during development prevents the dopaminergic deficit in hypothalaic arcuate nucleus in prolactin-deficient Ames dwarf mice. Endocrinology 133:1860-1870, 1993.
85. Berczi I, Nagy E, Kovacs K, Horvath E. Regulation of humoral immunity in rats by pituitary hormones. Acta Endocrinol 98:506-513, 1981.
86. Postel-Vinay MC, Coelho VM, Gagnerault MC, Dardenne M. Growth hormone stimulates the proliferation of activated mouse T lymphocytes. Endocrinology 138:1816-1820, 1997.
87. Bex F, Bartke A, Goldman BD, Dalterio S. Prolactin, growth hormone, luteinizing hormone receptors, and seasonal changes in testicular activity in the golden hamster. Endocrinology 103:2069-2080, 1978.
88. Saez JM. Leydig cells: Endocrine, paracrine, and autocrine regulation. Endocr Rev 15:574-626, 1994.
89. Steger RW, Chandrashekar V, Zhao W, Bartke A, Horseman N. Neuroendocrine and reproductive functions in male mice with targeted disruption of the prolactin gene. Endocrinology 139:3691-3695, 1998.
90. Bartke A, Chandrashekar V, Steger RW. Effects of growth hormone on neuroendocrine function. Acta Neurobiol Exp 56:833-842, 1996.
91. Russell JA, Leng G. Sex, parturition, and motherhood without oxytocin? J Endocrinol 157:343-359, 1998.
92. Ogawa S, Eng V, Taylor J, Lubahn DB, Korach KS, Pfaff DW. Roles of estrogen receptor-α-gene expression in reproduction-related behaviors in female mice. Endocrinology 139:5070-5081, 1998.